Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Thyroid Année : 2023

Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports

Fichier non déposé

Dates et versions

hal-04633710 , version 1 (03-07-2024)

Identifiants

Citer

Sophie Moog, Livia Lamartina, Mohamed-Amine Bani, Abir Al Ghuzlan, Luc Friboulet, et al.. Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports. Thyroid, 2023, 33 (11), pp.1368-1373. ⟨10.1089/thy.2023.0144⟩. ⟨hal-04633710⟩
1 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More